Effect of rhulFN-γ Treatment in Multibacillary Leprosy Patients

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 64, Issue 3, 1996, Pages 268-273

  Sampaio, Elizabeth P ^a   Malta, Ana M ^a   Sarno, Euzenir N ^a   Kaplan, Gilla ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; RECOMBINANT GAMMA INTERFERON;

ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; HUMAN; LEPROSY; TREATMENT OUTCOME;

CLOFAZIMINE; DAPSONE; DRUG THERAPY, COMBINATION; ERYTHEMA NODOSUM; HUMANS; INTERFERON-GAMMA, RECOMBINANT; LEPROSTATIC AGENTS; LEPROSY, BORDERLINE; LEPROSY, LEPROMATOUS; MYCOBACTERIUM LEPRAE; RIFAMPIN; SKIN; THALIDOMIDE;

EID: 0029850685     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. BERMUDEZ, L. E. and KAPLAN, G. Recombinant cytokines for controlling mycobacterial infections. Trends Microbiol. 3 (1995) 22-26.
2. KAPLAN, G., MATHUR, N. K., JOB, C. K., NATH, I. and COHN, Z. A. The effect of multiple IFN-γ injections on the disposal of Mycobacterium leprae. PNAS 86 (1989) 8073-8077.
3. KAPLAN, G., NUSRAT, A., SARNO, E. N., JOB, C. K., MCELRATH, J., PORTO, J. A., NATHAN, C. F. and COHN, Z. A. Cellular responses to the intradermal injection of recombinant human interferon-γ in lepromatous leprosy patients. Am. J. Pathol. 128 (1987) 345-353.
4. MAKONKAWKEYOON, S., LIMSON-POBRE, R. N. R., MOREIRA, A. L., SCHAUF, V. and KAPLAN, G. Thalidomide inhibits the replication of human immunodeficiency virus type 1. PNAS 90 (1993) 5974-5978.
5. NATHAN, C. F., KAPLAN, G., LEVIS, W. R., NUSRAT, A., WITMER, M. D., SHERWIN, S. A., JOB, C. K., HOROWITZ, C. R., STEINMAN, R. M. and COHN, Z. A. Local and systemic effects of low doses of recombinant interferon-γ after intradermal injection in patients with lepromatous leprosy. New Engl. J. Med. 315 (1986) 6-15.
6. NATHAN, C. F., SQUIRES, K., GRIFFO, W., LEVIS, W., VARGLESE, M., JOB, C. K., NUSRAT, A. R., SHERWIN, S., RAPPAPORT, S. SANDES, E., BURKHARDT, R. A. and KAPLAN, G. Widespread intradermal accumulation of mononuclear leukocytes in lepromatous leprosy patients treated systemically with recombinant interferon-γ. J. Exp. Med. 172 (1990) 1509-1512.
7. NATHAN, C. F. and YOSHIDA, R. Interferon-γ In: Inflammation: Basic Principles and Clinical Correlates. Gallin, J., Goldstein, I. and Snyderman, R., eds. New York: Raven Press, Ltd., 1988, pp. 229-251.
8. RIDLEY, D. S. and HILSON, G. R. F. A logarithmic index of bacilli in biopsies I. Method. Int. J. Lepr. 35 (1967) 184-186.
9. RIDLEY, D. S. and JOPLING, W. H. Classification of leprosy according to immunity; a five-group system. Int. J. Lepr. 34 (1966) 255-273.
10. SAMPAIO, E. P., MOREIRA, A. L., SARNO, E. N., MALTA, A. M. and KAPLAN, G. Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients. J. Exp. Med. 175 (1992) 1729-1737.
11. SAMPAIO, E. P., SARNO, E. N., GALLILLY, R., COHN, Z. A. and KAPLAN, G. Thalidomide selectively inhibits TNFa production by stimulated human monocytes. J. Exp. Med. 173 (1991) 699-703.
12. SAMUEL, N. M., GRANGE, J. M., SAMUEL, S., LUCAS, S., OWILLI, O. M., ADALLA, S., LEIGH, I. M. and NAVARRETTA, C. A study of the effects of intradermal administration of recombinant gamma interferon in lepromatous leprosy patients. Lepr. Rev. 58 (1987) 389-400.